Benzinga · Oct 16, 2026
Keybanc Maintains Overweight on Hinge Health, Raises Price Target to $140
Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $125 to $140.
HN
NYSE · HNGE
Hinge Health, Inc.
Healthcare · Medical - Healthcare Information Services
$116.90
Up+$1.62 (+1.41%)
Updated Oct 30, 2026, 8:43 AM
SID Score
6.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.93B
- P/E ratio
- -7.38
- Dividend yield
- 0.00%
- 52-week range
- $34.64 – $116.00
- Volume
- 2.14M
- Avg. volume
- 1.62M
Price performance · HNGE
HNGE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
HNGE closed at $116.90 after 21 trading sessions, up 19.36% for the selected period.
- Last close
- $116.90
- Period change
- +19.36%
- Period low
- $97.67
- Period high
- $116.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $114.09 | $117.55 | $113.56 | $116.90 | 2.14M |
| Oct 28, 2026 | $113.21 | $116.00 | $112.16 | $115.28 | 873.13K |
| Oct 27, 2026 | $111.60 | $114.405 | $111.01 | $113.90 | 1.28M |
| Oct 26, 2026 | $111.69 | $113.48 | $110.49 | $111.71 | 2.08M |
| Oct 23, 2026 | $109.51 | $112.58 | $109.14 | $111.52 | 1.56M |
| Oct 22, 2026 | $112.59 | $113.48 | $108.50 | $109.93 | 2.26M |
| Oct 21, 2026 | $108.16 | $112.24 | $107.8179 | $112.00 | 2.75M |
| Oct 20, 2026 | $103.64 | $108.00 | $103.30 | $107.51 | 4.09M |
| Oct 19, 2026 | $100.31 | $104.19 | $99.99 | $103.96 | 1.24M |
| Oct 16, 2026 | $106.53 | $106.7099 | $97.44 | $99.16 | 1.76M |
| Oct 15, 2026 | $103.42 | $105.80 | $102.305 | $104.96 | 1.69M |
| Oct 14, 2026 | $104.02 | $106.3228 | $100.75 | $105.00 | 1.62M |
| Oct 13, 2026 | $107.00 | $107.00 | $103.175 | $105.14 | 879.88K |
| Oct 12, 2026 | $102.29 | $104.925 | $100.90 | $104.82 | 1.34M |
| Oct 9, 2026 | $98.60 | $103.28 | $98.24 | $102.90 | 1.7M |
| Oct 8, 2026 | $97.36 | $98.75 | $96.04 | $98.00 | 912.33K |
| Oct 7, 2026 | $97.20 | $99.79 | $96.8396 | $97.86 | 2.65M |
| Oct 6, 2026 | $98.93 | $100.3599 | $96.0201 | $98.35 | 2.91M |
| Oct 5, 2026 | $99.00 | $99.805 | $97.363 | $98.35 | 3.18M |
| Oct 2, 2026 | $98.30 | $99.7296 | $96.95 | $97.67 | 975.35K |
| Oct 1, 2026 | $97.00 | $98.46 | $96.325 | $97.94 | 1.42M |
Latest HNGE news
The latest Smart Investors Daily articles mentioning HNGE.
Stock researchCompany · Overview
Company
Market Activity
Research & News
HNGE research
Overview
Company profile and research snapshot.
Company profile
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $57.63
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 26, 2026 | Stifel | Buy | — |
| Oct 16, 2026 | Keybanc | Overweight | — |
| Oct 12, 2026 | Barclays | Overweight | — |
| Sep 30, 2026 | Needham | Buy | — |
| Sep 22, 2026 | Baird | Neutral | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Oct 15, 2026
Hinge Health: Strong Growth, But Too Much Is Priced In
Hinge Health (HNGE) operates a digital musculoskeletal care platform, primarily targeting self-insured employers but expanding to fully insured and Medicare...
Benzinga · Oct 12, 2026
Barclays Maintains Overweight on Hinge Health, Raises Price Target to $110
Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $100 to $110.
Benzinga · Oct 7, 2026
'Hinge Health Sees Hardware Deals Ahead in Digital Health Push'- Bloomberg
https://www.bloomberg.com/news/articles/2026-10-07/hinge-health-sees-hardware-deals-ahead-in-digital-health-push
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
